Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195660 · ClinicalTrials.gov registry record · NA
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
A NA study, sponsored by ResMed.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03195660 is a NA study that was terminated before completion, run by ResMed. The registered enrollment target is 6 participants.
The verdict
NCT03195660, a NA study, was terminated before completion, sponsored by ResMed.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is designed to demonstrate feasibility of study conduct and that acceptable adherence to adaptive servo-ventilation (ASV) therapy can be achieved in recently hospitalized HFpEF patients with moderate to severe sleep apnea. All subjects meeting the criteria will receive ASV therapy.
Interventions
- DEVICE ASV Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2017-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03195660
The ClinicalTrials.gov registry entry for NCT03195660 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ResMed, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASV Therapy is the first listed.
NCT03195660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03195660 about?
NCT03195660 is a clinical study titled "Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study". This study is designed to demonstrate feasibility of study conduct and that acceptable adherence to adaptive servo-ventilation (ASV) therapy can be achieved in recently hospitalized HFpEF patients with moderate to severe sleep apnea. All subjects meeting the criteria will receive ASV therapy.
What is the current status of trial NCT03195660?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2017-06-26. Estimated completion is 2017-11-15.
What interventions are being tested in trial NCT03195660?
The interventions under investigation include: ASV Therapy (DEVICE).
Who is sponsoring clinical trial NCT03195660?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.